Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guess we'll find out, but it's a win/win for me. If it goes higher, the shares I've still got increase in value, that's a good thing and maybe I'll even buy back a few I sold. If it goes down in value, I'll buy the shares I sold back cheaper. Either way works for me.
I sold some trading shares that I had a nice gain on. If great news comes out tomorrow, I still have enough shares left to do pretty well for myself. Being out totally is one thing, but holding a core position and trading around it is something very different.
I may buy some back on a break above .16. There is some resistance at .15 and the 200 DMA at .16 so it'll likely take some serious volume to get through both of those numbers. Volume has been very good for the past few days and it closed strong today so it may be able to get through. If so, I'll be ready but if it fails at .15 or .16, I see a retrace back to the 50 DMA. That's usually the way it goes anyway.
Sold 2/3 of my position at an avg of around .1435. ACTC has had a great run and I still love the company and it's prospects as much as I did yesterday, but I will look to buy back on a pullback because I think it's run a little too far a little too fast. If it keeps moving higher, I still have enough shares to profit nicely, if not, I'll be buying again at lower prices.
Maybe they want to start initiating or re-starting clinical trials for other diseases. That could be one possibility. Also, just because the shares are authorized doesn't mean that they're all going to be issued. Maybe they know that there's really good news coming and the share price will likely pop and they want to have the opportunity to sell shares at higher levels. Maybe their potential Chinese partner wants to take an equity position in the stock. There are a lot of different possibilities...
By "rescued" do you mean that the deterioration of the rods and cones stop? If so, there is likely to be no improvement of the condition of the rods and cones then, right?
I wish for the patients involved that this was a miracle cure for blindness, but strictly from an investment perspective, Dry AMD is a $30 billion market, and that doesn't even include other treatments that ACT has in the pipeline should the use of embryonic stem cells for Stagardt's and Dry AMD eventually be approved by the FDA.
Pertaining to the expectations people have, I believe I discussed here previously that this treatment would likely not nor was it intended to reverse the vision loss patients have already suffered, but rather was meant to slow or stop the progression of the disease so the patients didn't lose any more vision than they already had, and someone (I believe it was someone who doesn't post here regularly but I don't recall) was implying that could/should. Oh well, whatever.
Hi Rocky. I was replying to another poster who said maybe they had regained all of their vision. I definitely understand that the rods and cones are destroyed, which is why there may be a small amount of visual acuity regained. In fact, I believe you were the "another poster" who I referenced. I've also gone over a few times on that this is a safety study. I know very well what to expect from the trial. I also know, however, that saying that there will never be improvement in visual acuity at all is also falese, they've seen it in 100% of the lab rats and mice. Since they say that embryonic stem cells can basically reprogram into any type of cell in the body, I don't think it's out of the realm of possibility that there could've been some regeneration of the rods and cones. Maybe it's impossible, I know.
What I'm hoping for is that the treatment is proven safe, they can determine the proper dosage and and maybe some degree of efficacy becomes apparent as well. I'm clearly not expecting people to regain most of their vision and I hope that the first paragraph of the post to which you responded shows that. I know that the intent of this treatment isn't to cure the blind. I used to think it was possible but you set me straight on that a long time ago. I'm not so sure all of the other posters here do understand that though.
I believe another poster here said awhile back that the rods and cones are destroyed in patients' eyes, whose disease has progressed far enough that they'd be used in these trials and though they may have some improvement in visual acuity, it wouldn't improve their vision greatly.
Maybe the rods and cones started regenerating which allowed for a little more improvement in visual acuity than originally expected? I don't even know if that's possible, but let's hope so....
Do we even know for sure that NEJM is going to be the one publishing the results?
There were a couple of small volume spikes earlier but nothing very close to that time. The real volume spike didn't start until after 3PM. Whatever the cause, I ain't complainin', that's for sure!
I'm not so sure that the price move was because of the rumor posted on ICELL, namely because it doesn't seem to provide any new information other than what Lanza had already said publicly and what most here had surmised based on his comments. Not sure what time it was posted, but the volume has been pretty decent all day.
How reputable was the source?
Just voted yes with my shares as well. Between what people have posted here and on IV, I blieve that there have been around 1.5 million yes votes so far. I think it will pass overwhelmingly. I'm assuming Rabin, Lanza and all of the board members will be voting yes as well.
I would suggest that you put him on ignore, his agenda is clear. That's what I did anyway. Just make sure that your ignore filter is on under your settings or it won't work.
Nothing these clowns say is gonna change the DD you've done and the potential of the company, all it can do is get you to second guess yourself and sell when you shouldn't. That's exactly what they're trying to accomplish. To me, it's just annoying, unnecessary riff-raff.
I wonder if anyone has made ACT management aware of these accusations that have been made about them supposedly selling shares "privately" and not filing the sales with the SEC as required by law. It seems to me that absent proof, that would constitute libel.
Another interesting thing I noticed is that other than DDLS, none of the other posters who are, shall we say, "negative" on ACTC seem to have a very good command of the English language. I find that interesting as well. Wondering if it could be a coordinated effort by a foreign entity...Maybe I'm just being paranoid but it seems like an strange coincidence.
I heard Dr. Schwartz say something to the effect that the patients knew it was "very unlikely" that they were going to have any improvement in vision. I actually found that to be an interesting choice of words on his part, because he didn't say "because they knew that they weren't going to get any improvement in their vision or function", which to me would mean that they didn't expect any improvement in visual acuity and they as expected, they didn't get any.
Rabin stated that so far the trials had gone better than expected and that they had been "surprised" by some of what they had seen. I'm not sure that simple engraftment (implantation) would be better than what they expected or surprising to them, because after all, engraftment is what needs to happen in order for the later stages of the trials to be successful. Now, if it was "highly unlikely" that they would have any improvement in visual acuity but they did, I would classify that as "better than expected" and "surprising".
You may very well be correct and it's very likely that you're either correct, or there may be results that fall somewhere in-between engraftment and improvement in visual acuity that would be better than expected and surprising. I agree that the market is not going to get overly excited about anything less than improvement in visual acuity. The good news is that the stock certainly hasn't run up in anticipation of the results, and since we already know that so far it has proven to be safe based on the DSMB voting unanimously to allow them to inject the next four patients, hopefully if the results show anything better than expected has occurred, the stock will hold steady or maybe see a little upside depending on how much better than expected the results are. I'm holding out some hope that there was some improvement in visual acuity though certainly not expecting it, but as Dr Schwartz said and you pointed out, I also know it is very unlikely that happened, but if it did, it would be a nice surprise for sure.
I wouldn't include me on that list farview, I just use the numbers I read in the PR's and the SEC filings. Rocky is definitely the best source for getting the complete picture, being able to tie all the parts of the different filings, settlements etc together to come up with a bottom line #. The important thing is that I think the confusion has been cleared up as to how many shares will be issued, to whom they will be issued, for which settlement (the "global" settlement vs the Midsummer settlement) they will be issued, and the breakdown of the total # of shares that will be issued.
Thanks for bringing it up Ison, I think it probably cleared up a lot of confusion for many people (myself included).
I hear what you're saying Rocky. I guess for the sake of 10 days it may not matter much one way or the other, but if there does end up being mass selling, as a shareholder, it would be nice to potentially get a reprieve from the selling for a few days, though I guess you're right that in the interest of fairness to the recipients of the shares they probably should issue them all at the same time. I believe the 8K ACT filed on 09/22 when this all started indicated a total potential liability of 428 million shares, excluding the Midsummer settlement (which also wasn't included as part of the 428 million ACT provided since the Midsummer deal had been completed previous to that filing). Assuming that the last party settles for the anticipated number of shares, it seems that ACT may get away issuing about 42-50 million (or roughly 10% less) shares than originally anticipated per the 8k filed on 09/22, assuming that my math of 428 million potential shares was correct.
39,514,859 (Alpha) + 8 million (convertible notes) + 380,000,000 (additional warrants) = ~428 million.
http://biz.yahoo.com/e/110922/actc.ob8-k.html
Thanks Rocky, great info, that explains it perfectly.
So the additional 50 million shares aren't actually being issued as part of the "global settlement" itself, but rather a settlement that ACT made with Midsummer prior to and outside of the "global settlement" being reached, however, the ~50 million shares will need to be issued to Midsummer within 10 days after the AS increase is approved if I'm reading it correctly. That makes sense, thanks for clarifying. I hope they at least wait the full 10 days they are allowed to issue the shares to Midsummer to allow the market to digest any shares that are sold immediately upon issuance to the firms receiving the "global settlement" shares so if there is a lot of selling immediately, it may at least temporarily relieve some of the pressure on the stock.
Thanks Rocky for all of the effort you put in both here and on iCell, it's much appreciated.
Hey Rocky/elllk. Maybe what I recall is what people were speculating at the time. At some point it was also mentioned that they were paying some sort of share penalty for not issuing shares to someone on time? So much misinformation is thrown around these boards all the time it's hard to keep it all straight, especially if like me, you don't read the board every day and where there have been periods of a week or more that I haven't even looked at it. I go by the numbers released in the PR's and the SEC filings, though I know that in reading Rocky's posts in the past, those #'s may not be truly reflective, basically due to the mess the company recently got itself into that has made this more confusing than it ever should've been in the first place.
All I know is that the 8k filed says that they're issuing 240.5 million shares in conjunction with the global settlement. The number from the post Ison referenced was 50 million higher than what the PR and the 8k said. I guess the obvious question is where are the other 50 million shares coming from and to whom are they being issued?
In the future, I would simply recommend that any questions on the share structure be referred to Rocky (especially when in regard to posts he made), or simply visit his forum on iCell. I don't even pretend to have the understanding that he does, so it's best to just go to the source.
Hey farview. Hope you're having a good New Year so far.
To answer your questions/comments:
"I also read somewhere, that we shouldn't just assume that there might not be some cash as well as shares as a part of those remaining four. Obviously, to the best of my knowledge we don't know."
I would say that the way these agreements are written, unless ACT agreed to settle with the the other four for cash (which I highly doubt unless it was on extremely favorable terms to ACT that the plaintiffs wouldn't possibly accept), they're simply not getting any cash. The precedent, IMO, has been set from the other court cases that have been resolved that no cash will be involved. I'll say anything's possible, but I think it's highly, highly unlikely.
"Do you know (I can't find it anywhere), if there are any conditions of time or quantity restrictions on the litigants ability to sell? That may be a very big issue in terms of what Rabin and the board decide to release pr wise and when they release it?"
I don't know for sure, but I highly doubt there is any provision that in any way limits the litigants' ability to sell.
"My take is it's silly to think, barring language restriction in the awarded shares, that there won't be massive selling by the successful litigants. This is a different breed, not really investors in the great hope of ACTC, and they already have a good profit for their dollars and, imo most will take it, especially those in poor cash positions? What do you think?"
I'm not sure on this one. It wouldn't surprise me if there were heavy selling, however, it wouldn't surprise me if there weren't heavy selling either. Different firms may do different things with the shares once they receive them. I think that they're going to want to maximize their profits and though they all got the shares for free, it's not going to benefit any of them if they all just dump the shares on the open market at the same time. The first few firms that were awarded shares were awarded prior to the end of 2011, so depending on their financial performance for the year, they may have dumped their shares to goose their returns a little bit. The other companies may not be in quite as much of a hurry because the end of the year won't be looming when they receive their shares. It's tough to tell. I'd definitely expect some selling. I'm not sure how much or what news may accompany the announcement that AS was increased that could determine the ease with which those shares could be absorbed were they to be sold by the firms receiving them.
"The other way out thought that sort of intrigues me is, do you think there's any feasibility/realistic possibility, that there's a provision we're not aware of, that allows/welcomes the successful litigants to transfer/sell their shares immediately to a 'quiet/unknown' JV partner waiting in the wings to acquire the shares? (Perhaps a Roche, there's been so much speculation there?)"
I have no idea on this, though that would certainly be a game-changer. Going from looking at large dilution to firms who could sell at any time time to having a JV JV with a major biotech who absorbed all those shares in a private transaction at a set price. That would be one of the better outcomes, but certainly not one I would expect or predict would happen, though it would certainly be nice if it did.
"While I'm gabbing away, I was somewhat intrigued by Lanza's most recent tweet (sorry no link) in which he seems to play down some unbelievable news, beyond very good news , being released soon? Perhaps he was just stopping the wild expectations of actual sight improvement, beyond initial safety, engraftment and stabilization?"
Not sure what tweet you're referring to. The only tweets from him I remember seeing posted here recently referred to a medical journal releasing the initial results and people being happy that they waited, and then another apologizing for the timing of the previous tweet as some shares were dumped right around the time he tweeted that. I'd be interested in reading it if anyone has a link though. The question to me is "is what the market considers to be big news the same as what the scientific community considers to be big news"? I guess we'll find out the answer to that question soon enough. The one comment that Lanza made that has stuck with me the most was the one about both initial patients wanting their other eye injected. If they're blind, I'm not sure that engraftment would be enough for them to want something done that they knew wasn't a part of the clinical trial to begin with (i.e. the trial was set up so only one eye from each patient was injected). My personal opinion is that Lanza should just refrain from giving anything other than the standard boiler-plate responses to questions when asked until the initial results are released. Trying to make a guessing game out of the results on Twitter is just simply not smart IMO.
Hi Ison. I'm assuming the part you want me to comment on is the number of new shares that the poster said will be issued at the time that the AS increase is approved. Though 292 million may technically be right (though also if we're being technical the other ~50 million aren't actually required to be issued to meet the terms of the global settlement itself) I'm going with the official number put out by Rabin in the PR and in the SEC filing that are required to be issued to settle the global settlement, and here's why:
I do remember that certain shareholders (basically Rabin/Lanza I believe) lent ACT shares to cover the shortfall of shares needed to comply with the shares awarded (and issued) to Alpha, Cranshire and Black Mountain cases ordered them to give those companies at trial, so I would assume that those ~50 million additional shares referenced in that post would include the shares that need to be issued to repay management the shares they lent the company so they would not go into default on the judgments and those ~50 million shares have already been issued to (and likely already sold by) Alpha, Cranshire and Black Mountain, so IMO any negative impact specifically from those ~50 million shares on share price has already been felt. Any new shares issued in excess of the 240.5 million that are required to be issued as part of the global settlement will be going back into the hands of Rabin/Lanza, and I don't believe that Rabin/Lanza are going to just dump the shares that they're repaid on the market. Does that make sense?
Hope that helps!
The clinical trials and the settlement are exclusive of one another, and one doesn't impact the other at all as far as I know. Once the settlement is done, it's over with the exception of a potential maximum of about 100 million more shares, there shouldn't be any more lawsuits regardless of the trial results. I'm hoping that we get a PR on Tuesday stating that the next 4 patients have been injected. Rabin said on the last conference call that they should be injecting them by the end of 2011, but since we haven't gotten a PR stating that they've been injected yet, my guess is that the next injections haven't happened yet.
Everyone else I know is waiting to get in at 4 cents too, which is exactly why I highly doubt you'll ever get shares at that price. I'll never say never, but IMO it's highly unlikely.
Two corrections:
#1) It's not 300 million "worth" of shares being issued. This would imply 3.5 billion shares being issued at the current price of 8 cents. I think what you meant you say was "around 300 million shares"...but see #2) below
#2) There will be 240.5 million shares issued, likely on 01/25/12.
I'm correcting #2) for the 2nd time and am posting a link. In fairness, however, there is still one lawsuit outstanding that has apparently yet to be settled. I believe the estimates I heard on iCell are that they'll probably eventually have to issue about 90 million shares in addition to the 240.5 million that will likely be issued January 25th, assuming that the AS increase is approved. There were also 4 other parties that would be entitled to shares under the global settlement that ACTC hasn't been able to reach, but Rabin said in aggregate, they would only get an estimated 8 million shares combined si it's pretty irrelevant in the scheme of things.
"According to the terms of the agreements, ACT will issue approximately 240.5 million shares in total to this group of holders, in exchange for a mutual two-way release of any current and/or future claims. The settlement agreements further provide that the shares will be delivered following the approval of an increase in the company’s authorized shares by the company’s stockholders. "
http://finance.yahoo.com/news/ACT-Announces-Settlements-bw-1031098134.html?x=0
I totally agree with that. I'm assuming that the increase in AS will be approved on Jan 24th and am looking further out than that, considering that for some reason they didn't include authorization for a reverse split as something to be voted on by the shareholders as part of the special meeting. Though I initially thought this was a positive, I believe it could also be a negative. There's two possibilities: 1) Rabin doesn't think that they're ultimately going to need to do a reverse split because they have some blockbuster news and/or results to report or because they're in negotiations to be bought out so it won't matter anyway or b) he doesn't see a reason to have it voted on because he doesn't see an event in the near future would put the company in enough of a position of strength that he'd be willing to risk doing a reverse split.
As a shareholder, I'm obviously hoping for option A. I guess I just don't see what it would hurt to get the r/s split option voted on and available unless he just knows for some reason he isn't going to need it. 2012 should be a very interesting year.
Hope everyone has a happy and safe New Year's!
I don't recall Rabin ever ruling out a reverse split, I believe he said that if/when they ended up doing a reverse split, it would done be from a position of strength, i.e. in combination with some other good news that would likely simultaneously drive institutional and analyst interest so that there would be buying interest after the r/s was completed and the company was listed on a major exchange.
I think the problem that they have is that they're still going to be traded on the OTC market for at least a time after a potential r/s would be completed because as far as I know they couldn't get listed the same day, so they'll still have to go through the application process. I'm sure they're share price would need to stay above a certain price threshhold for a period of time after for their application to be approved, so if they do an r/s, they need to cut the number of shares by enough that if the stock gets hit after the r/s completed, the share price is virtually guaranteed to still remain above the whatever threshold is required by whatever exchange they're applying to.
2012:
High: .624
Low: .0673
Close: .535
When you say "current share structure" do you mean assuming that the 1 billion AS increase is approved on the 01/24?
Elysse, one problem is being that the share price is so low, it attracts day-traders and penny-flippers which makes it hard to maintain a stable share price without huge % swings. Further, we have zero analyst coverage or institutional support for the stock due to the fact that it trades for .09 and is a bulletin board stock. I understand Rabin wanting to wait until we're in a position of strength to announce a reverse split, or possibly depending on how good the news is, not have to do one at all, but given the likely increase of AS, I would say that NOT doing a reverse split and still achieving the necessary share price to get listed on a major exchange will be all but impossible now.
I've agreed with Rabin's decision to wait and totally understand his reasoning given that I've seen many times the negative impact on the share price after a company completes a reverse split, however, I'm not sure that's the case here given that I think going to a major exchange would give us instant credibility, analyst coverage and institutional buying. I'd like to see him wait until we have some very positive news to report, but if the share price continues to decline, it just feeds on itself and makes it very hard to get back to a respectable share price where the chart looks decent enough to attract buyer again, because as positive as I am on the future of the company, looking at the chart, it appears to be in a death spiral. Hopefully something extremely positive that will be the catalyst for a big move higher happens soon. If not, I think Rabin needs to just do the reverse split and get it over with. IMO there are one of two things that could make this happen: the announcement of clinical trial results stating that the patients injected so far have both experienced a dramatic increase in visual acuity, or a major US or European partnership/JV. If one of those two announcements isn't imminent, Rabin should just get the split over with. I find the fact that he didn't put the reverse split on the table for vote on 01/24 says that he expects to release some major news in the near future, but that may just be wishful thinking on my part...
Farview, now I have a few questions and clarifications for you:
1) at what date(s) and approximate price did you buy your shares back at?
2) if you think the stock is going to go down to .035-.04 why are you still holding your shares?
3) why would you proclaim in an earlier post that "you were right and I was wrong" when you bought your shares back prior to the most recent decline, then tried to circle back to your original opinion and claim that you were right all along? Don't you think that calls your credibility into question?
4) Everyone reading your posts should take what you say with a grain of salt because given the decline that you're projecting for ACT and the fact that you claim to have a full long position in the stock completely contradict each other. Since I believe talk is cheap and actions speak louder than words, I've come to the following conclusion:
a) you're lying about the fact that you're long the stock
OR
b) you're unconvinced by your own argument that a large decline in share price that you've stated over and over you feel is inevitable is in the cards
Again, I don't mind reading points of view that are different than mine, but when I read someone say "I think the stock price is going to be cut by 50-75% from it's current level but I haven't sold a share", I can't take anything they say seriously after that. Hope that clarifies things even further for you.
Farview, when the stock was under .12 I posted the math showing why the stock was oversold. It was a pretty simple math based on the max potential % increase of shares outstanding and the price the stock was trading at at the time this was announced. I don't feel too bad about stating that the stock was oversold when Rabin came out and stated the same thing on a conference all a couple of weeks later using the exact same logic I had.
I don't believe I gave anyone advice, as I usually try not to, but rather stated what I personally am doing or will do if certain situations present themselves. In this case, I said I remember saying that I personally would add under .10 which I did (and actually added some a slightly higher levels as well). That's a far cry from what rango and/or DDLS were doing with their "the sky is falling, dump all your shares now" routine. It's also a far cry from what you're doing now: stating that you think the stock will go down between 50-75% from the current share price, but inexplicably, you're still holding your shares. Who knows, maybe it WILL go that low because as you state, there is a lot of dilution coming. It will depend on what, if any, news comes in the interim and when the companies that will be issued the stock decide to sell the shares that are issued to them. All I will say is that if it goes that low, the share price will have delined by almost 75% based on lawsuit-related dilution of 27%. As such, assuming no change in the fundamental story, I will be buying large quantities of shares starting around .05 should it get that low. So as not to give "advice", not only am I not recommending what if any action anyone should take in the event that the share price drops precipitously, I really could care less what anyone else does.
In re: to the other part of your post about who was "right" and who was "wrong": eventually the stock ended up going lower, however, before you complete your touchdown dance and spike the ball, let's not forget to mention a couple of inconvenient facts that you're leaving out:
1) Shortly after I said that I thought the dilution was priced in and that the stock was oversold, it bounced to about .135, up somewhere in the neighborhood of 15-20% in short order.
2) At the time we were having this original debate, you stated you had sold half of your shares. Before this most recent decline to .075, you stated that you thought things we're looking better and you stated that you had bought the shares you had sold back. Now, despite the decision you made to buy the shares you had sold back and your stated rationale for doing so, you want to go back to your original argument from months ago after you took actions clearly indicating that you had changed your mind and now say that you were right and I was wrong. You're now further saying that you think the stock is going down between 50-75% from current levels, but you haven't sold your shares. Am I the only one confused by this? Despite the fact that you keep repeating the same things over and over, your conviction is clearly lacking because once again, your actions don't match the opinions you're stating here. Sorry, but I give you zero credit for being right because based on your subsequent actions, your attempt to come back now and say that you were right all along is totally and transparently disingenious, so much so that another poster (I believe it may have been Elysse) called you out on it recently when you tried to make a similar "I told you so" claim.
Lastly, in regard to the # of shares that will be issued: the PR that ACT released announcing the global settlement clearly states that the number of shares to be issued in conjunction with the settlements currently made are 240 million. I believe that you're adding in the shares that have already been issued to (and likely already sold by) Alpha and the other party as a result of the judges' orders in those cases. I believe that number came out to around 52 million shares (38 million in the Alpha case and 14 million in the other case). There is still one more large settlement that will occur that from the estimates I've heard (based on the # of shares they originally purchased and the lowest price at which they were subsequently issued which has been set by the courts in the Alpha case and the other case) should be around 90 million shares. I believe the rough amount of shares that will be issued in total in conjunction with this this who issue will be about 382 million, give or take a little. This includes both the 52 million shares that have already been issued as well as the 90 million shares that are not currently being counted in the # provided for the global settlement.
Once again, farview, the original deal was for shares (I don't mean the global settlement, I mean the terms of the original warrant agreements), not cash. It's not at their discretion to choose. They aren't getting cash unless the increase in AS doesn't pass and ACT can't produce the shares that the companies are owed, so if we're to assume that the AS increase is going to pass, let's put the notion of any of them getting cash to bed now. Another thing I'd like to mention is that the amount of shares that ACT has currently agreed to have issued is 240 million. When the last case is settled that number will rise to over 300 million total, however, the shares from the last settlement may not hit the market until after the 240 million do depending on when that settlement is completed.
Other than the one large chunk of shares ACT will end up having to issue to the company they haven't settled with, I believe Rabin said that the maximum number of shares that these companies would be entitled to would be something in the area of 8 million.
Lastly, I don't think I'm "going on the offensive" by asking you to refrain from posting the same thoughts and concerns over and over. It accomplishes nothing. Everyone gets it. Do whatever you, want when I've had enough of hearing you recycle the same stuff over and over, I'll throw you on my ignore list and the problem will be solved. I'm sure others will do the same. I'd prefer not to do that because I do appreciate reading your opinions and insights once or twice, but reading the same thing 5X a day is a little much for me personally.
If the results are going to be published in a medical journal, wouldn't it make sense for ACT to announce when they will be released ahead of time, since this isn't something they'll be PR'ing themselves? If Rabin knows, it may not be a bad time to provide the publication date assuming it will be occurring in the not-too-distant future. I would also expect a PR soon announcing that the next four patients received their injections as Rabin stated that they would be injected by the end of the year. Not that the announcement of the next injections will move the stock substantially higher, but it would at least be a sign that things are progressing again...Just holding tight for now.
I actually think there's a lot to be excited about, I just don't know when it's going to announced. I suspect it will be fairly soon. All I'm really saying is that assuming nothing changes, can we just assume that you will continue to think it's going a lot lower? Again, I have no problem with someone being bearish on the share price, it just gets really old reading it 5 times a day from the same person. That's all I'm saying, so keep it in mind.
Farview, I think by now after you've posted it probably 15 times in the past two or three days that you think the share price may get to .035-.04 per share, everyone here understands your take on the situation and why your opinion is what it is. What do you think that you're accomplishing by posting it over and over and over again? Are you just going to continue responding to every 4th post about how you think the share price is going dramatically lower? You did this exact same thing last time the share price dropped, and now the share price is dropping again you're back doing the exact same thing. What you're doing now is no better than a couple of other posters here who I've previously mentioned that I now have on ignore because I believe they provide nothing of value do on a daily basis, although at least Gastro is consistently negative and doesn't change his tune depending on what the stock price is doing at any given time.
I think what ultimately happens with the share price will depend largely on what news comes out and when. If, for instance, on Jan 25th (assuming that the AS increase goes through) results are announced stating that not only have the injections proven safe and that there was a thickening of the RPE layer of cells, but that there was also noticeable and unexpected improvement in visual acuity, what do you think is gonna happen then? My guess is that like last time there was major news and the stock ran big, there are going to be multiple days 100 million plus shares traded that would likely soak up most of whatever new shares are issued. Rabin is stupid and knows exactly what is going on. He also know exactly what will happen if all of these shares are issued with no news, and my guess is that the results of that would be the share price going to the .035-.04 level you've referenced multiple times lately. I'm sure by now he has a pretty good idea when the medical journal will be publishing the prelim results. I wouldn't be surprised that the timing of that release will coincide very close with the issuance of the additional shares for the global settlement.
To be clear, I have no problem with people stating here that they think I DO have a problem with is people that continue to post the same negative sentiments over and over and over, multiple times daily, and I'm sure others here are geting just as sick of reading it as I am. If you're not bashing, prove it and stop posting the same thing over and over and over. We all understand you're opinion, there's no need for additional clarification. Thanks!
Ya gotta love that management is willing to do what they can to issue PR's like this to protect the shareholders as much as they can. I believe it's the 2nd or 3rd time they've done this. Though they can't release the actual prelim results of the clinical trials yet, I have to give them credit for reassuring everyone that everything is going fine with the clinical trials. I think the best we can hope for is that they DO release the results prior to issuing the rest of the shares needed to complete the global settlement, because one thing I do have agree with DDLS about is if 70 million shares can cause this type of downdraft in the share price, it's a little scary to think what could happen to the share price when they issue the rest of the shares if we're still trading at these levels. I believe this is an intentional takedown, and whoever is selling timed this in coordination with the market being slow due to the holidays. Hopefully they sell all the shares they have soon....
DDLS, you cheerlead when the stock's going up and complain incessently and act like you knew it was coming all along when it declines. You just joined gastro and rango on my ignore list.